Allergic Fungal Sinusitis

AFS: Pathophysiology - Fungal Fiesta Fright

• Nature: Allergic reaction to extramucosal fungi; non-invasive.
• Hypersensitivity:
  • Predominantly Type I (IgE-mediated) against fungal antigens.
  • Possible Type III (immune complex) involvement.
• Causative Fungi: Primarily dematiaceous molds (e.g., Bipolaris, Curvularia, Alternaria).
• Host Factor: Atopic individuals (history of allergy, asthma).
• Key Pathological Features:
  • Allergic Mucin: Thick, eosinophilic, "peanut butter-like" consistency.
    • Contains fungal hyphae (no tissue invasion), numerous eosinophils, Charcot-Leyden crystals.
  • Chronic inflammation causes sinus expansion.

⭐ AFS is a non-invasive fungal sinusitis driven by a Type I hypersensitivity reaction to extramucosal fungi, not tissue invasion.

AFS: Clinical Features - Sinus Siege Symptoms

• Chronic Sinusitis Symptoms:
  • Nasal blockage, persistent congestion.
  • Thick, discolored discharge (often unilateral).
  • Facial pain/pressure, headache.
  • ↓ Sense of smell (hyposmia/anosmia).
• Nasal Polyposis: Frequently seen, can be extensive.
• Allergic Mucin: Hallmark finding!
  • Thick, tenacious, "peanut butter" or "machine grease" consistency.
  • Greenish-black to brown.
• History of atopy (asthma, eczema, allergic rhinitis).

⭐ Key presentation: chronic rhinosinusitis, nasal polyposis, and thick, tenacious, 'peanut butter-like' eosinophilic mucin.

AFS: Diagnosis - Spotting Spores Sleuth

• Nasal Endoscopy:
  • Reveals thick, tenacious, eosinophilic mucin (classic "peanut butter" or "machine oil" appearance).
• Imaging:
  • CT Scan (PNS):
    • Sinus opacification.
    • Central hyperattenuation (pathognomonic).
    • Bony erosion/remodeling (no frank invasion).
  • MRI:
    • T1: Hypointense.
    • T2: Markedly hypointense (signal void).
• Histopathology (HPE) of Mucin:
  • Allergic mucin: Abundant eosinophils, Charcot-Leyden crystals.
  • Fungal hyphae (non-invasive); positive fungal stain.
• Allergy Testing:
  • ↑ Total IgE & fungal-specific IgE.
  • Positive skin prick test to fungal allergens.
• Bent & Kuhn Diagnostic Criteria (Key):
  1. Type I hypersensitivity (skin test or serology).
  2. Nasal polyposis.
  3. Characteristic CT findings.
  4. Eosinophilic mucin with fungal hyphae (no tissue invasion).
  5. Positive fungal stain or culture of sinus contents.

⭐ CT scans distinctively show central hyperattenuation in opacified sinuses; histopathology reveals allergic mucin with fungal hyphae and Charcot-Leyden crystals without tissue invasion. Bent and Kuhn criteria are key for diagnosis.

AFS: Management - Fungus Fight Formula

⭐ Management cornerstone: surgical debridement (FESS) followed by long-term corticosteroids (systemic/topical); role of antifungals is debated.

• Goals: Eradicate fungus, ↓ inflammation, ventilate sinuses, prevent recurrence.
• Surgical: FESS (Functional Endoscopic Sinus Surgery)
  • Essential: Remove all allergic mucin & thick fungal debris.
  • Aim: Patent sinuses for drainage & topical drug delivery.
• Medical (Post-FESS):
  • Corticosteroids: Mainstay.
    • Systemic (Oral Prednisolone): Initial (e.g., 0.5-1 mg/kg/day), slow taper over weeks/months.
    • Topical (Nasal sprays): Long-term daily use for maintenance & recurrence prevention.
  • Nasal Saline Irrigation: Daily, high-volume; clears secretions.
  • Adjunctive Therapies (Consider):
    • Antifungals: Controversial. Systemic (e.g., Itraconazole) not routine. Topical may be an option.
    • Immunotherapy (allergen-specific): For atopy, may ↓ recurrence.
• Follow-up: Regular endoscopic surveillance crucial for recurrence.

High‑Yield Points - ⚡ Biggest Takeaways

• AFS is a Type I hypersensitivity reaction to fungal antigens in immunocompetent, often atopic individuals.
• Characterized by nasal polyposis and allergic mucin (thick, tenacious, eosinophilic, with fungal hyphae).
• Allergic mucin contains Charcot-Leyden crystals and numerous eosinophils; fungi are non-invasive.
• CT scans typically reveal hyperattenuation (hyperdensity) within affected sinuses; bony erosion can occur.
• Diagnosis is guided by the Bent and Kuhn criteria.
• Management primarily involves surgical debridement (FESS) followed by corticosteroids (systemic and topical).
• Recurrence is common, necessitating long-term follow-up and management strategies for optimal outcomes.